Advances in biomarker development and potential application for preeclampsia based on pathogenesis
Preeclampsia (PE) is a pregnancy-specific complication that seriously threatens the health and safety of mothers and infants. The etiology of PE has not been fully elucidated, and no effective treatments are currently available. A pregnant woman with PE often has to make a tough choice on either end...
Main Authors: | Nan Liu, Yu-Na Guo, Li-Kun Gong, Bing-Shun Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | European Journal of Obstetrics & Gynecology and Reproductive Biology: X |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590161320300132 |
Similar Items
-
An Update Review of the Pathogenesis Hypothesis in Preeclampsia
by: Rui Lian, et al.
Published: (2022-07-01) -
Potential biomarkers for late-onset and term preeclampsia: A scoping review
by: Luhao Han, et al.
Published: (2023-03-01) -
Identification of novel first-trimester serum biomarkers for early prediction of preeclampsia
by: Mingxi Liu, et al.
Published: (2023-09-01) -
Placenta-derived exosomes: potential biomarkers of preeclampsia
by: Pillay P, et al.
Published: (2017-10-01) -
The maternal blood lipidome is indicative of the pathogenesis of severe preeclampsia
by: Bing He, et al.
Published: (2021-01-01)